PATENT CLAIM ANALYSIS

Application Number: 15942767
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-08
Patent Classification: ["424", "239100"]

Abstract:
A method is disclosed for blocking or reducing a physiological reaction in a mammal to the interaction of IgE antibodies present in said mammal upon contact with the corresponding antigen, by the administration to said mammal of a therapeutically effective amount of a neurotoxin (CnT) derived from Clostridia sp.

Claim (Index 1):
A method of treating an allergic condition or a symptom thereof in a patient in need thereof, comprising administering an effective amount of a neurotoxin (CnT) to a body structure and/or a nerve and nerve ganglia supplying the body structure of the patient, wherein the CnT is isolated or purified from a species of  Clostridia  selected from the group consisting of  C. botulinum, C. butyricum  and  C. beratti ., and wherein the allergic condition is selected from the group consisting of rhinitis, asthma, gastroenterititis, serous otitis, sinusitis and dermatitis.

Metadata:
- Claim Count in Document: 3.0
- Percentile: 91.0
- Lexical Diversity: 1.29268
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['12976317', '12976421', '13304092', '12976483', '12976459']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7769342412519106
- 35 USC 102 Novelty (BERT): 0.5442356603745104
- Combined Prediction Score: 0.7536643831641705
- Mean Citation Score: 395.201702
- Max Citation Score: 395.37912
- Similarity Product: 370.31240180686

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test